During the past decade, Parkinson's and Neurodegenerative Disorders Clinic conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Parkinson's and Neurodegenerative Disorders Clinic" are "Parkinson's Disease" (2 trials) and "Idiopathic Parkinson's Disease" (1 trials). Many other conditions were trialed in "Parkinson's and Neurodegenerative Disorders Clinic" in a lesser frequency.

Most popular intervention types in "Parkinson's and Neurodegenerative Disorders Clinic" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "2 mg perampanel" (1 trials), "4 mg perampanel" (1 trials), "IPX066 145 mg LD" (1 trials), "IPX066 195 mg LD" (1 trials) and "IPX066 245 mg LD" (1 trials). Other intervention names were less common.

The vast majority of trials in "Parkinson's and Neurodegenerative Disorders Clinic" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Parkinson's and Neurodegenerative Disorders Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Parkinson's and Neurodegenerative Disorders Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Parkinson's and Neurodegenerative Disorders Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".